InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Shankar Gopi. Director active across 1 company, notably Larimar Therapeutics, Inc.. In total, 4 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €17k. History available since 7 December 2023. The latest transaction was filed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Shankar Gopi is a declarant linked to Larimar Therapeutics, Inc., where he is Chief Development Officer. He has 4 filings in total, and across the 4 most recent filings available, buy transactions total 17333 EUR, sell transactions total 0 EUR, with a date range from 2023-12-08 to 2026-01-27. The most frequent transaction nature is Attribution.